Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Masimo Corporation
MASI
NASDAQ·Healthcare·Medical - Devices·Mkt cap $9.4B
$179.95
▲ 0.00%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$125.94 - $179.99
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 6.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary Signal Extraction Technology (SET) with measure-through motion capability
- Comprehensive Rainbow platform ecosystem for multiple physiological monitoring parameters
- Integrated hospital automation solutions creating sticky customer relationships
- Strong intellectual property portfolio and established brand recognition in medical monitoring
Bear Case
2 risks
- Average volatility.
- Significant premium - growth priced in
Growth
Stable outlook
Increasing adoption of noninvasive monitoring in hospitals and home care settings
Value
Significant premium - growth priced in
Momentum
Stable
+1.0% over 3m
Quality
Excellent
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying MASI right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Aug 4, 2026
MAY 5, 2026
Reported EPS of $1.10 vs $1.41 consensus (-22.0% surprise). Revenue of $403.6M vs $398.7M expected (+1.2%).
EPS surprise · last 4Q
0 of 1 beats
Q2 26
-22.0%
Next: Aug 4, 2026
Revenue trend · last 8Q
—
—
—
—
+8%
-26%
-31%
+8%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 26
Q1 26
$343.9M
$504.6M
$600.7M
$372.0M
$370.9M
$371.5M
$412.5M
$403.6M
Margins · last 8Q
Gross
62.1%
Operating
19.2%
Profit
14.2%
Wall Street consensus
3 analysts · 0% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
0%
Hold
100%
Sell
0%
Median Price Target
—
Latest: Raymond James · Mar 27, 2026
vs Industry
How MASI stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related
Peers & themes
Peers
No peer data available.
Themes
No themes assigned.